E-LIB Suche - Ergebnisse für: Takanuma, Masayuki

1

Pharmacokinetics, safety, tolerability, and immunogenicity ..:

Boyce, Malcolm ; Wilkes, Denisa ; Kaito, Hidekuni..
Int. Journal of Clinical Pharmacology and Therapeutics. 60 (2022) 6 - p. 280-290 , 2022

Link: https://doi.org/10.5414/..

2

Comparison of two biosimilarity studies of FKB327 with the ..:

Yonemura, Takuma ; Yazawa, Rie ; Haranaka, Miwa...
BMC Pharmacology and Toxicology. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

3

P1404A PHASE 2 OPEN-LABEL, SINGLE-ARM, FIRST JAPANESE STUDY..:

Fukagawa, Masafumi ; Kinoshita, Jun ; Takanuma, Masayuki..
Nephrology Dialysis Transplantation. 35 (2020) Supplement_3 - p. , 2020

Link: https://doi.org/10.1093/..

4

Efficacy and safety of benralizumab in Japanese patients wi..:

Ohta, Ken ; Adachi, Mitsuru ; Tohda, Yuji...
Allergology International. 67 (2018) 2 - p. 266-272 , 2018

Link: https://doi.org/10.1016/..

5

Benralizumab Reduces Exacerbations in Japanese Patients wit..:

FitzGerald, J Mark ; Ohta, Ken ; Adachi, Mitsuru...
Journal of Allergy and Clinical Immunology. 139 (2017) 2 - p. AB10 , 2017

Link: https://doi.org/10.1016/..

6

Comparison of two biosimilarity studies of FKB327 with the ..:

Yonemura, Takuma ; Yazawa, Rie ; Haranaka, Miwa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742919/. , 2022

Link: http://www.ncbi.nlm.nih...

7

Comparison of two biosimilarity studies of FKB327 with the ..:

Takuma Yonemura ; Rie Yazawa ; Miwa Haranaka...
https://doi.org/10.1186/s40360-021-00545-3. , 2022

Link: https://doi.org/10.1186/..

8

Efficacy and safety of benralizumab in Japanese patients wi..:

Ken Ohta ; Mitsuru Adachi ; Yuji Tohda...
http://www.sciencedirect.com/science/article/pii/S1323893017301570. , 2018

Link: https://doi.org/10.1016/..

9

Additional file 1 of Comparison of two biosimilarity studie..:

Takuma Yonemura (11922224) ; Rie Yazawa (11922227) ; Miwa Haranaka (11922230)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Comparison_of_two_biosimilarity_studies_of_FKB327_with_the_adalimumab_reference_product_randomized_phase_1_studies_of_single-blind_single-dose_subcutaneous_injection_in_healthy_Japanese_male_participants/18093200. , 2022

Link: https://doi.org/10.6084/..